AID Contributes to Accelerated Disease Progression in the TCL1 Mouse Transplant Model for CLL
Adaptive somatic mutations conferring treatment resistance and accelerated disease progression is still a major problem in cancer therapy. Additionally in CLL, patients receiving novel, efficient drugs frequently become treatment refractory and eventually relapse. Activation-induced deaminase (AID)...
Main Authors: | Maria Schubert, Franz Josef Gassner, Michael Huemer, Jan Philip Höpner, Ekaterina Akimova, Markus Steiner, Alexander Egle, Richard Greil, Nadja Zaborsky, Roland Geisberger |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-05-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/13/11/2619 |
Similar Items
-
Evidence for Non-Cancer-Specific T Cell Exhaustion in the Tcl1 Mouse Model for Chronic Lymphocytic Leukemia
by: Thomas Parigger, et al.
Published: (2021-06-01) -
Detecting Bacterial–Human Lateral Gene Transfer in Chronic Lymphocytic Leukemia
by: Ekaterina Akimova, et al.
Published: (2022-01-01) -
RNA Editing Alters miRNA Function in Chronic Lymphocytic Leukemia
by: Franz J. Gassner, et al.
Published: (2020-05-01) -
Adenosine Deaminase and Guanosine Deaminase Activities in Sera of Patients with Viral Hepatitis
by: Kalkan Ahmet, et al.
Published: (1999-01-01) -
Role of serum and pleural adenosine deaminase activity compared to pleural fluid analysis in patients with pleural effusion of various etiology
by: Mubasheer Ali, et al.
Published: (2023-01-01)